Omnicell Investor Presentation Deck
Total Year Revenue Composition.
GAAP ($Million)
Connected Devices, Software Licenses,
& Other
Consumables
Technical Services
Advanced Services
Total Revenue
2
Advanced Services % of Total Revenue
Recurring % of Total Revenue
© 2023 Omnicell, Inc.
Recurring vs
Non
Recurring
Non
Recurring
Category
Product
Recurring Product
Recurring Service
Recurring Service
Actual
TY-2020
$560
$76
$202
$54
$892
6%
37%
Year over
Year
(YoY)
Change %
-2%
-12%
4%
24%
-1%
Actual
TY-2021
$739
$73
$207
$113
$1,132
10%
35%
YOY
Change %
32%
-3%
2%
109%
27%
Actual
TY-2022
$828
$75
$207
$186
$1,296
14%
36%
YOY
Change %
12%
3%
0%
65%
14%
YOY
Updated
Guidance Change %
TY-2023 (Mid-Point)
$740-$760
$215-$225
$205-$215
$1,160-$1,200
18%
1. Connected Devices, Software Licenses, and other include, but are not limited to, XT Series automated dispensing systems and products related to Central Pharmacy Dispensing Service and IV Compounding Service.
2. Includes Central Pharmacy Dispensing Service (service portion), IV Compounding Service (service portion), EnlivenHealth solutions, Specialty Pharmacy Services, 340B solutions, Inventory Optimization Service, and other software
solutions.
-17%
6%
13%
-9%
14View entire presentation